Stock 4585 UMN PHARMA INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Company UMN Pharma Inc.

Equities

4585

JP3944320005

Biotechnology & Medical Research

Business Summary

UMN Pharma Inc. is a Japan-based biotechnology company mainly engaged in the biopharmaceuticals development business. The Company is engaged in the development, manufacturing and sales of biopharmaceuticals based on the baculovirus expression vector system (BEVS) manufacturing platform. The Company's pipelines include seasonal influenza vaccine UMN-0502, pandemic influenza vaccine UMN-0501, pandemic influenza vaccine UMN-0901 and norovirus/rotavirus vaccine UMN-2003.

Managers

Managers TitleAgeSince
Kazufumi Katayama CEO
 Chief Executive Officer - -

Members of the board

Members of the board TitleAgeSince
Kazufumi Katayama CEO
 Chief Executive Officer - -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 6 1 ( 16.67 %) 0 16.67 %

Company contact information

UMN Pharma, Inc.

8F, Lucid Square Shin-Yokohama 2-14-30 Shin-Yokohama

222-0033, Yokohama

+

http://www.umnpharma.com
address UMN Pharma Inc.(4585)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Sector Bio Therapeutic Drugs

1st Jan change Capi.
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
-1.17% 102B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+2.87% 96.09B
ARGENX SE Stock argenx SE
+2.13% 22.28B
BIONTECH SE Stock BioNTech SE
-14.77% 21.4B
GENMAB A/S Stock Genmab A/S
-8.79% 18.14B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-39.98% 17.02B
BEIGENE, LTD. Stock BeiGene, Ltd.
-13.21% 16.09B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+8.55% 13.83B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+35.75% 11.97B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. 4585 Stock
  4. Company UMN Pharma Inc.